Walleye Trading
DCPH

Walleye Trading’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Walleye Trading’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-19,300
Closed -$179K – 5811
2022
Q1 		$179K Buy
+19,300
New +$164K ﹤0.01% 3881
2021
Q3 		– Sell
-7,400
Closed -$271K – 5841
2021
Q2 		$271K Buy
7,400
+4,600
+164% +$178K ﹤0.01% 3612
2021
Q1 		$126K Sell
2,800
-2,700
-49% -$126K ﹤0.01% 3972
2020
Q4 		$314K Sell
5,500
-24,500
-82% -$1.45M ﹤0.01% 3098
2020
Q3 		$1.54M Buy
30,000
+29,500
+5,900% +$1.45M 0.01% 1312
2020
Q2 		$30K Buy
+500
New +$26.7K ﹤0.01% 3920

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Walleye Trading's DCPH Position: Q1 2024 in Review

Walleye Trading sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2024, closing a stake of 14,269 shares — an estimated $230K sold.

Walleye Trading first reported a position in DCPH in Q3 2020 and held it in 4 quarters. The position peaked at $627K in Q3 2020. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

  • Walleye Trading reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 14,269 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $230K.
  • Walleye Trading first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Walleye Trading's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $627K in Q3 2020.
  • 177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.